Clinical Trial Update: Single-ascending Dose Study of Kylo-12 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 single-ascending-dose study of Kylo-12 in healthy subjects to assess safety and pharmacokinetics for hypertriglyceridemia; the trial is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Kylo-12 (Kylo-12)

Snippet

Sponsor: Kylonova (Xiamen) Biopharma co., LTD. | Conditions: Hypertriglyceridemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING